by McKesson Ventures | Jun 13, 2018 | Portfolio News
Propeller Health has partnered up with Aptar Pharma, which last year generated $800 million selling drug dispensation devices such as inhalers and injectors to drug companies. Aptar and Propeller Health will digitally connect these devices to Propeller’s software via...
by McKesson Ventures | Jun 12, 2018 | Press Releases
Pharmapacks today announced that it has raised $32.5 million in a strategic round led by CPG company RB. Additional investments were made by McKesson Ventures, Sealed Air, and The Emerson Group. Pharmapacks also sold a minority stake as part of the round for an...
by McKesson Ventures | Jun 11, 2018 | Press Releases
Propeller Health announced today that McKesson Ventures has contributed an undisclosed amount to its $20 million strategic funding round. The funding will allow Propeller Health to continue developing connected medicines for the treatment of chronic respiratory...
by McKesson Ventures | Jun 9, 2018 | Portfolio News
Over the past 10 years, a lot of consideration has been given to how technology can be used to help care for people living with dementia. Voice recognition systems such as the Amazon Echo will never tire of repeated inquiries about the date and time. This interactive...
by McKesson Ventures | Jun 9, 2018 | Portfolio News
At last weekend’s American Society of Clinical Oncology annual meeting, GRAIL released results of a study that shows the potential for lung cancer to be detected with a blood test. The survey evaluated 127 patients with lung cancer and 580 controls. The researchers...
